Review



human liver whole tissue lysate  (Novus Biologicals)


Bioz Verified Symbol Novus Biologicals is a verified supplier
Bioz Manufacturer Symbol Novus Biologicals manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 92

    Structured Review

    Novus Biologicals human liver whole tissue lysate
    Human Liver Whole Tissue Lysate, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 92/100, based on 3 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/human liver whole tissue lysate/product/Novus Biologicals
    Average 92 stars, based on 3 article reviews
    human liver whole tissue lysate - by Bioz Stars, 2026-04
    92/100 stars

    Images



    Similar Products

    92
    Novus Biologicals human liver whole tissue lysate
    Human Liver Whole Tissue Lysate, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/human liver whole tissue lysate/product/Novus Biologicals
    Average 92 stars, based on 1 article reviews
    human liver whole tissue lysate - by Bioz Stars, 2026-04
    92/100 stars
      Buy from Supplier

    92
    Bio-Techne corporation human liver tissue
    Human Liver Tissue, supplied by Bio-Techne corporation, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/human liver tissue/product/Bio-Techne corporation
    Average 92 stars, based on 1 article reviews
    human liver tissue - by Bioz Stars, 2026-04
    92/100 stars
      Buy from Supplier

    90
    Kaltenbach GmbH dielectric contrast between normal and tumor ex-vivo human liver tissue
    Dielectric Contrast Between Normal And Tumor Ex Vivo Human Liver Tissue, supplied by Kaltenbach GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/dielectric contrast between normal and tumor ex-vivo human liver tissue/product/Kaltenbach GmbH
    Average 90 stars, based on 1 article reviews
    dielectric contrast between normal and tumor ex-vivo human liver tissue - by Bioz Stars, 2026-04
    90/100 stars
      Buy from Supplier

    92
    Exosome Diagnostics human liver tissue
    Human Liver Tissue, supplied by Exosome Diagnostics, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/human liver tissue/product/Exosome Diagnostics
    Average 92 stars, based on 1 article reviews
    human liver tissue - by Bioz Stars, 2026-04
    92/100 stars
      Buy from Supplier

    90
    Novus Biologicals human hcc tissue microarray tma
    Identification of downstream target genes commonly upregulated by mitochondrial defect and NFE2L1. Transcriptome data of four cell lines (Ch-L and SNU387 harboring active mitochondria, and SNU354 and SNU423 harboring defective mitochondria) were obtained from our previous report . Two independent sets of SNU387 cells transfected with pcDNA-NFE2L1 plasmid (NFE2L1_OE) for 48 h and of SNU423 cells with siNFE2L1 (NFE2L1_KD) for 72 h were applied to cDNA <t>microarray</t> for transcriptome profiling. ( A ) Venn diagram of commonly upregulated genes with mitochondrial defect (Mito defect, SNU354 and SNU423 vs. Ch-L and SNU387) and NFE2L1-dependent regulation. ( B ) Heatmaps show the expression of 10 commonly upregulated genes in four hepatoma cell lines (left), NFE2L1-depleted SNU423 cells (middle), and NFE2L1-overexpressed SNU387 cells (right). Each column and row represent independent samples and the indicated genes, respectively. Red and blue color indicates the high and low expression, respectively. ( C , E ) Validation of four target mRNA levels by qRT-PCR. ( D , F ) Validation of four target protein levels by Western blot analysis. #1 and #2 indicate two different siRNAs for NFE2L1. ** p < 0.01 vs. pcDNA or siNC by the Student t -test. ( G ) Associations of NFE2L1 with the 10 commonly upregulated genes were evaluated using the TCGA-LIHC cohort ( n = 371). Pearson’s product moment correlation test was performed. The correlation estimate and the p-value with statistical significance are marked. ( H ) Boxplot for STX12 expression level of primary <t>HCC</t> tissues from the TCGA-LIHC cohort. Bottom, middle, and top lines of each box indicate the first quartile, median, and third quartile values, respectively. Whiskers represent the minimum and maximum values. For comparison, primary tumors were divided into two groups, based on the median expression level of NFE2L1 and NDUFA9: a group with both above the median NFE2L1 level and below the median NDUFA9 level, a group with both below the median NFE2L1 level and above the median NDUFA9 level. p -value from Wilcoxon t-test is indicated.
    Human Hcc Tissue Microarray Tma, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/human hcc tissue microarray tma/product/Novus Biologicals
    Average 90 stars, based on 1 article reviews
    human hcc tissue microarray tma - by Bioz Stars, 2026-04
    90/100 stars
      Buy from Supplier

    90
    Cosmo Bio USA total rna from human liver tumor tissue
    Identification of downstream target genes commonly upregulated by mitochondrial defect and NFE2L1. Transcriptome data of four cell lines (Ch-L and SNU387 harboring active mitochondria, and SNU354 and SNU423 harboring defective mitochondria) were obtained from our previous report . Two independent sets of SNU387 cells transfected with pcDNA-NFE2L1 plasmid (NFE2L1_OE) for 48 h and of SNU423 cells with siNFE2L1 (NFE2L1_KD) for 72 h were applied to cDNA <t>microarray</t> for transcriptome profiling. ( A ) Venn diagram of commonly upregulated genes with mitochondrial defect (Mito defect, SNU354 and SNU423 vs. Ch-L and SNU387) and NFE2L1-dependent regulation. ( B ) Heatmaps show the expression of 10 commonly upregulated genes in four hepatoma cell lines (left), NFE2L1-depleted SNU423 cells (middle), and NFE2L1-overexpressed SNU387 cells (right). Each column and row represent independent samples and the indicated genes, respectively. Red and blue color indicates the high and low expression, respectively. ( C , E ) Validation of four target mRNA levels by qRT-PCR. ( D , F ) Validation of four target protein levels by Western blot analysis. #1 and #2 indicate two different siRNAs for NFE2L1. ** p < 0.01 vs. pcDNA or siNC by the Student t -test. ( G ) Associations of NFE2L1 with the 10 commonly upregulated genes were evaluated using the TCGA-LIHC cohort ( n = 371). Pearson’s product moment correlation test was performed. The correlation estimate and the p-value with statistical significance are marked. ( H ) Boxplot for STX12 expression level of primary <t>HCC</t> tissues from the TCGA-LIHC cohort. Bottom, middle, and top lines of each box indicate the first quartile, median, and third quartile values, respectively. Whiskers represent the minimum and maximum values. For comparison, primary tumors were divided into two groups, based on the median expression level of NFE2L1 and NDUFA9: a group with both above the median NFE2L1 level and below the median NDUFA9 level, a group with both below the median NFE2L1 level and above the median NDUFA9 level. p -value from Wilcoxon t-test is indicated.
    Total Rna From Human Liver Tumor Tissue, supplied by Cosmo Bio USA, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/total rna from human liver tumor tissue/product/Cosmo Bio USA
    Average 90 stars, based on 1 article reviews
    total rna from human liver tumor tissue - by Bioz Stars, 2026-04
    90/100 stars
      Buy from Supplier

    90
    Human Protein Atlas hcc tumor and normal liver tissue base on the human protein atlas database
    Identification of downstream target genes commonly upregulated by mitochondrial defect and NFE2L1. Transcriptome data of four cell lines (Ch-L and SNU387 harboring active mitochondria, and SNU354 and SNU423 harboring defective mitochondria) were obtained from our previous report . Two independent sets of SNU387 cells transfected with pcDNA-NFE2L1 plasmid (NFE2L1_OE) for 48 h and of SNU423 cells with siNFE2L1 (NFE2L1_KD) for 72 h were applied to cDNA <t>microarray</t> for transcriptome profiling. ( A ) Venn diagram of commonly upregulated genes with mitochondrial defect (Mito defect, SNU354 and SNU423 vs. Ch-L and SNU387) and NFE2L1-dependent regulation. ( B ) Heatmaps show the expression of 10 commonly upregulated genes in four hepatoma cell lines (left), NFE2L1-depleted SNU423 cells (middle), and NFE2L1-overexpressed SNU387 cells (right). Each column and row represent independent samples and the indicated genes, respectively. Red and blue color indicates the high and low expression, respectively. ( C , E ) Validation of four target mRNA levels by qRT-PCR. ( D , F ) Validation of four target protein levels by Western blot analysis. #1 and #2 indicate two different siRNAs for NFE2L1. ** p < 0.01 vs. pcDNA or siNC by the Student t -test. ( G ) Associations of NFE2L1 with the 10 commonly upregulated genes were evaluated using the TCGA-LIHC cohort ( n = 371). Pearson’s product moment correlation test was performed. The correlation estimate and the p-value with statistical significance are marked. ( H ) Boxplot for STX12 expression level of primary <t>HCC</t> tissues from the TCGA-LIHC cohort. Bottom, middle, and top lines of each box indicate the first quartile, median, and third quartile values, respectively. Whiskers represent the minimum and maximum values. For comparison, primary tumors were divided into two groups, based on the median expression level of NFE2L1 and NDUFA9: a group with both above the median NFE2L1 level and below the median NDUFA9 level, a group with both below the median NFE2L1 level and above the median NDUFA9 level. p -value from Wilcoxon t-test is indicated.
    Hcc Tumor And Normal Liver Tissue Base On The Human Protein Atlas Database, supplied by Human Protein Atlas, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/hcc tumor and normal liver tissue base on the human protein atlas database/product/Human Protein Atlas
    Average 90 stars, based on 1 article reviews
    hcc tumor and normal liver tissue base on the human protein atlas database - by Bioz Stars, 2026-04
    90/100 stars
      Buy from Supplier

    90
    Shanghai Biochip Co. Ltd 45 pairs of human liver cancer and their matched adjacent non-tumor tissue arrays
    Identification of downstream target genes commonly upregulated by mitochondrial defect and NFE2L1. Transcriptome data of four cell lines (Ch-L and SNU387 harboring active mitochondria, and SNU354 and SNU423 harboring defective mitochondria) were obtained from our previous report . Two independent sets of SNU387 cells transfected with pcDNA-NFE2L1 plasmid (NFE2L1_OE) for 48 h and of SNU423 cells with siNFE2L1 (NFE2L1_KD) for 72 h were applied to cDNA <t>microarray</t> for transcriptome profiling. ( A ) Venn diagram of commonly upregulated genes with mitochondrial defect (Mito defect, SNU354 and SNU423 vs. Ch-L and SNU387) and NFE2L1-dependent regulation. ( B ) Heatmaps show the expression of 10 commonly upregulated genes in four hepatoma cell lines (left), NFE2L1-depleted SNU423 cells (middle), and NFE2L1-overexpressed SNU387 cells (right). Each column and row represent independent samples and the indicated genes, respectively. Red and blue color indicates the high and low expression, respectively. ( C , E ) Validation of four target mRNA levels by qRT-PCR. ( D , F ) Validation of four target protein levels by Western blot analysis. #1 and #2 indicate two different siRNAs for NFE2L1. ** p < 0.01 vs. pcDNA or siNC by the Student t -test. ( G ) Associations of NFE2L1 with the 10 commonly upregulated genes were evaluated using the TCGA-LIHC cohort ( n = 371). Pearson’s product moment correlation test was performed. The correlation estimate and the p-value with statistical significance are marked. ( H ) Boxplot for STX12 expression level of primary <t>HCC</t> tissues from the TCGA-LIHC cohort. Bottom, middle, and top lines of each box indicate the first quartile, median, and third quartile values, respectively. Whiskers represent the minimum and maximum values. For comparison, primary tumors were divided into two groups, based on the median expression level of NFE2L1 and NDUFA9: a group with both above the median NFE2L1 level and below the median NDUFA9 level, a group with both below the median NFE2L1 level and above the median NDUFA9 level. p -value from Wilcoxon t-test is indicated.
    45 Pairs Of Human Liver Cancer And Their Matched Adjacent Non Tumor Tissue Arrays, supplied by Shanghai Biochip Co. Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/45 pairs of human liver cancer and their matched adjacent non-tumor tissue arrays/product/Shanghai Biochip Co. Ltd
    Average 90 stars, based on 1 article reviews
    45 pairs of human liver cancer and their matched adjacent non-tumor tissue arrays - by Bioz Stars, 2026-04
    90/100 stars
      Buy from Supplier

    Image Search Results


    Identification of downstream target genes commonly upregulated by mitochondrial defect and NFE2L1. Transcriptome data of four cell lines (Ch-L and SNU387 harboring active mitochondria, and SNU354 and SNU423 harboring defective mitochondria) were obtained from our previous report . Two independent sets of SNU387 cells transfected with pcDNA-NFE2L1 plasmid (NFE2L1_OE) for 48 h and of SNU423 cells with siNFE2L1 (NFE2L1_KD) for 72 h were applied to cDNA microarray for transcriptome profiling. ( A ) Venn diagram of commonly upregulated genes with mitochondrial defect (Mito defect, SNU354 and SNU423 vs. Ch-L and SNU387) and NFE2L1-dependent regulation. ( B ) Heatmaps show the expression of 10 commonly upregulated genes in four hepatoma cell lines (left), NFE2L1-depleted SNU423 cells (middle), and NFE2L1-overexpressed SNU387 cells (right). Each column and row represent independent samples and the indicated genes, respectively. Red and blue color indicates the high and low expression, respectively. ( C , E ) Validation of four target mRNA levels by qRT-PCR. ( D , F ) Validation of four target protein levels by Western blot analysis. #1 and #2 indicate two different siRNAs for NFE2L1. ** p < 0.01 vs. pcDNA or siNC by the Student t -test. ( G ) Associations of NFE2L1 with the 10 commonly upregulated genes were evaluated using the TCGA-LIHC cohort ( n = 371). Pearson’s product moment correlation test was performed. The correlation estimate and the p-value with statistical significance are marked. ( H ) Boxplot for STX12 expression level of primary HCC tissues from the TCGA-LIHC cohort. Bottom, middle, and top lines of each box indicate the first quartile, median, and third quartile values, respectively. Whiskers represent the minimum and maximum values. For comparison, primary tumors were divided into two groups, based on the median expression level of NFE2L1 and NDUFA9: a group with both above the median NFE2L1 level and below the median NDUFA9 level, a group with both below the median NFE2L1 level and above the median NDUFA9 level. p -value from Wilcoxon t-test is indicated.

    Journal: Cancers

    Article Title: Mitochondrial Respiratory Defect Enhances Hepatoma Cell Invasiveness via STAT3/NFE2L1/STX12 Axis

    doi: 10.3390/cancers12092632

    Figure Lengend Snippet: Identification of downstream target genes commonly upregulated by mitochondrial defect and NFE2L1. Transcriptome data of four cell lines (Ch-L and SNU387 harboring active mitochondria, and SNU354 and SNU423 harboring defective mitochondria) were obtained from our previous report . Two independent sets of SNU387 cells transfected with pcDNA-NFE2L1 plasmid (NFE2L1_OE) for 48 h and of SNU423 cells with siNFE2L1 (NFE2L1_KD) for 72 h were applied to cDNA microarray for transcriptome profiling. ( A ) Venn diagram of commonly upregulated genes with mitochondrial defect (Mito defect, SNU354 and SNU423 vs. Ch-L and SNU387) and NFE2L1-dependent regulation. ( B ) Heatmaps show the expression of 10 commonly upregulated genes in four hepatoma cell lines (left), NFE2L1-depleted SNU423 cells (middle), and NFE2L1-overexpressed SNU387 cells (right). Each column and row represent independent samples and the indicated genes, respectively. Red and blue color indicates the high and low expression, respectively. ( C , E ) Validation of four target mRNA levels by qRT-PCR. ( D , F ) Validation of four target protein levels by Western blot analysis. #1 and #2 indicate two different siRNAs for NFE2L1. ** p < 0.01 vs. pcDNA or siNC by the Student t -test. ( G ) Associations of NFE2L1 with the 10 commonly upregulated genes were evaluated using the TCGA-LIHC cohort ( n = 371). Pearson’s product moment correlation test was performed. The correlation estimate and the p-value with statistical significance are marked. ( H ) Boxplot for STX12 expression level of primary HCC tissues from the TCGA-LIHC cohort. Bottom, middle, and top lines of each box indicate the first quartile, median, and third quartile values, respectively. Whiskers represent the minimum and maximum values. For comparison, primary tumors were divided into two groups, based on the median expression level of NFE2L1 and NDUFA9: a group with both above the median NFE2L1 level and below the median NDUFA9 level, a group with both below the median NFE2L1 level and above the median NDUFA9 level. p -value from Wilcoxon t-test is indicated.

    Article Snippet: Briefly, paraffin-embedded tissue slides of human HCC tissue microarray (TMA) (NBP2-30221, Novus Biologicals) were deparaffinized and rehydrated.

    Techniques: Transfection, Plasmid Preparation, Microarray, Expressing, Biomarker Discovery, Quantitative RT-PCR, Western Blot, Comparison

    STX12 is a key regulator of hepatoma cell invasiveness. ( A , B ) SNU423 cell was transfected with STX12 siRNA for 72 h. ( A ) Cell invasion assay using a Matrigel-coated Transwell system. Representative invaded cell images are shown in the right panel. ** p < 0.01 vs. siNC by the Student t-test. ( B ) Western blot (left) and cell growth rate (right). #1 and #2 indicate two different siRNAs for STX12. ( C , D ) Ch-L was transfected with STX12 plasmid for 48 h. ( C ) Cell invasion assay. Representative invaded cell images are shown in the right panel. ** p < 0.01 vs. GFP by the Student t-test. ( D ) Western blot (left) and cell growth rate (right). ( E – G ) SNU423 clone, which was stably suppressing NFE2L1 with sgNFE2L1 RNA, was further infected with lentivirus harboring STX12 or GFP. ( E ) Cell invasion assay. ** p < 0.01 vs. sgNC; # < 0.05 vs. GFP by the Student t -test. ( F ) Cell growth. ( G ) Western blot. ( H ) Immunohistochemistry of HCC tissue microarray, as described in ‘Materials and Methods’. Lower panel shows representative images for NFE2L1 and STX12 immunostaining. ( I , J ) Boxplots of the normalized enrichment score (NES) for EMT signature of the primary HCC tissues from the TCGA_LIHC dataset. Bottom, middle, and top lines of each box indicate the first quartile, median, and third quartile values, respectively. Whiskers represent the minimum and maximum values. p -values from Welch two-sample t -test are indicated. ( I ) Tumor samples were divided into high and low groups, according to the expression level of NFE2L1 (left) or STX12 (middle), respectively, as described in ‘Materials and Methods’. To evaluate the effect of co-expression on the EMT signature, tumor samples were divided into two groups, based on the co-expression level of both NFE2L1 and STX12 (right). ( J ) The NFE2L1 and STX12 co-expressing group (right panel of I) was further subdivided into an H ( n = 11) and L group ( n = 23) according to the NDUFA9 expression level. ( K ) Overall survival (OS) time of the H and L group was compared based on the Kaplan–Meier survival analysis. Statistical significance for KM survival was estimated by the Cox–Mantel log-rank test.

    Journal: Cancers

    Article Title: Mitochondrial Respiratory Defect Enhances Hepatoma Cell Invasiveness via STAT3/NFE2L1/STX12 Axis

    doi: 10.3390/cancers12092632

    Figure Lengend Snippet: STX12 is a key regulator of hepatoma cell invasiveness. ( A , B ) SNU423 cell was transfected with STX12 siRNA for 72 h. ( A ) Cell invasion assay using a Matrigel-coated Transwell system. Representative invaded cell images are shown in the right panel. ** p < 0.01 vs. siNC by the Student t-test. ( B ) Western blot (left) and cell growth rate (right). #1 and #2 indicate two different siRNAs for STX12. ( C , D ) Ch-L was transfected with STX12 plasmid for 48 h. ( C ) Cell invasion assay. Representative invaded cell images are shown in the right panel. ** p < 0.01 vs. GFP by the Student t-test. ( D ) Western blot (left) and cell growth rate (right). ( E – G ) SNU423 clone, which was stably suppressing NFE2L1 with sgNFE2L1 RNA, was further infected with lentivirus harboring STX12 or GFP. ( E ) Cell invasion assay. ** p < 0.01 vs. sgNC; # < 0.05 vs. GFP by the Student t -test. ( F ) Cell growth. ( G ) Western blot. ( H ) Immunohistochemistry of HCC tissue microarray, as described in ‘Materials and Methods’. Lower panel shows representative images for NFE2L1 and STX12 immunostaining. ( I , J ) Boxplots of the normalized enrichment score (NES) for EMT signature of the primary HCC tissues from the TCGA_LIHC dataset. Bottom, middle, and top lines of each box indicate the first quartile, median, and third quartile values, respectively. Whiskers represent the minimum and maximum values. p -values from Welch two-sample t -test are indicated. ( I ) Tumor samples were divided into high and low groups, according to the expression level of NFE2L1 (left) or STX12 (middle), respectively, as described in ‘Materials and Methods’. To evaluate the effect of co-expression on the EMT signature, tumor samples were divided into two groups, based on the co-expression level of both NFE2L1 and STX12 (right). ( J ) The NFE2L1 and STX12 co-expressing group (right panel of I) was further subdivided into an H ( n = 11) and L group ( n = 23) according to the NDUFA9 expression level. ( K ) Overall survival (OS) time of the H and L group was compared based on the Kaplan–Meier survival analysis. Statistical significance for KM survival was estimated by the Cox–Mantel log-rank test.

    Article Snippet: Briefly, paraffin-embedded tissue slides of human HCC tissue microarray (TMA) (NBP2-30221, Novus Biologicals) were deparaffinized and rehydrated.

    Techniques: Transfection, Invasion Assay, Western Blot, Plasmid Preparation, Stable Transfection, Infection, Immunohistochemistry, Microarray, Immunostaining, Expressing